Invesco Ltd. lessened its holdings in shares of Agilent Technologies, Inc. (NYSE:A – Get Rating) by 36.0% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 3,609,318 shares of the medical research company’s stock after selling 2,029,335 shares during the quarter. Invesco Ltd. owned about 1.20% of Agilent Technologies worth $477,620,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business. BlackRock Inc. raised its stake in Agilent Technologies by 2.5% during the 1st quarter. BlackRock Inc. now owns 30,082,335 shares of the medical research company’s stock valued at $3,980,792,000 after purchasing an additional 730,116 shares during the period. Vanguard Group Inc. increased its stake in Agilent Technologies by 1.1% in the 1st quarter. Vanguard Group Inc. now owns 24,531,170 shares of the medical research company’s stock worth $3,246,209,000 after acquiring an additional 261,435 shares during the last quarter. State Street Corp increased its stake in Agilent Technologies by 3.1% in the 4th quarter. State Street Corp now owns 13,370,324 shares of the medical research company’s stock worth $2,134,572,000 after acquiring an additional 401,106 shares during the last quarter. Geode Capital Management LLC increased its stake in Agilent Technologies by 1.8% in the 4th quarter. Geode Capital Management LLC now owns 5,866,133 shares of the medical research company’s stock worth $934,437,000 after acquiring an additional 103,871 shares during the last quarter. Finally, Impax Asset Management Group plc increased its stake in Agilent Technologies by 13.6% in the 4th quarter. Impax Asset Management Group plc now owns 4,540,510 shares of the medical research company’s stock worth $724,892,000 after acquiring an additional 544,288 shares during the last quarter.
Agilent Technologies Price Performance
Agilent Technologies stock opened at $137.63 on Monday. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.94 and a quick ratio of 1.41. The stock has a market cap of $40.74 billion, a price-to-earnings ratio of 31.35, a price-to-earnings-growth ratio of 2.71 and a beta of 1.06. The firm has a 50-day moving average of $128.66 and a two-hundred day moving average of $127.01. Agilent Technologies, Inc. has a 1 year low of $112.52 and a 1 year high of $179.31.
Analysts Set New Price Targets
A number of analysts have issued reports on the company. StockNews.com raised Agilent Technologies from a “buy” rating to a “strong-buy” rating in a research note on Friday, August 26th. Cowen lifted their price objective on Agilent Technologies to $160.00 in a research note on Monday, August 22nd. Wells Fargo & Company lifted their price objective on Agilent Technologies from $130.00 to $135.00 and gave the stock an “equal weight” rating in a research note on Wednesday, August 17th. UBS Group initiated coverage on Agilent Technologies in a report on Wednesday, July 20th. They issued a “buy” rating and a $139.00 target price for the company. Finally, Evercore ISI increased their price target on Agilent Technologies to $145.00 in a report on Monday, August 22nd. Four investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $151.31.
Insider Activity at Agilent Technologies
In other news, VP Padraig Mcdonnell sold 2,506 shares of the company’s stock in a transaction that occurred on Thursday, September 8th. The shares were sold at an average price of $134.33, for a total value of $336,630.98. Following the completion of the sale, the vice president now owns 15,320 shares of the company’s stock, valued at approximately $2,057,935.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.
About Agilent Technologies
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.
- Get a free copy of the StockNews.com research report on Agilent Technologies (A)
- Can Electronic Arts Buck the Downturn in Videogaming?
- Dollar General is the Big Fish in Little Ponds Across the U.S.
- Here’s Why the CPI Report will Dictate the Market Bottom
- MarketBeat: Week in Review 9/5 – 9/9
- Prepare For A Record-Setting Quarter For Cyber Security Stocks
Receive News & Ratings for Agilent Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Agilent Technologies and related companies with MarketBeat.com's FREE daily email newsletter.